SynaptixBio
PrivateLast Round
Grant
Aug 22, 2024
Total Funding Raised
$19.88M
Company Overview
SynaptixBio operates in Healthcare & Life Sciences and is based in Oxford. Its latest recorded funding round was a Grant round in August 2024.
SynaptixBio is a biotechnology company that develops gene silencing therapies for severe leukodystrophies and other childhood neurodegenerative diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
SynaptixBio Comparables
Compare SynaptixBio with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Vico Therapeutics | 78% | |
| Velvio GmbH | 78% | |
| Sinfonia Biotherapeutics | 71% |
For institutional investors. Book with your work email.
SynaptixBio Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Aug 22, 2024 | ||||
| Grant | Dec 23, 2023 | ||||
| Seed | Apr 28, 2023 | ||||
| Seed | Apr 1, 2021 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
SynaptixBio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Innovate UK | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 22, 2024
$2.6M grant received from Innovate UK.
For institutional investors. Book with your work email.
SynaptixBio Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about SynaptixBio's valuation, stock price, and market status.
Is SynaptixBio a public or private company?
SynaptixBio is a private company.
What is the current stock price of SynaptixBio?
SynaptixBio is a private company, so its shares have no public market price. Caplight tracks SynaptixBio's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is SynaptixBio worth (valuation)?
Valuation information for SynaptixBio is not publicly available.
Can I buy SynaptixBio stock?
SynaptixBio shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was SynaptixBio's last funding round?
SynaptixBio's most recent funding round was Grant on August 22, 2024.
Who are the main investors in SynaptixBio?
Key investors in SynaptixBio include Innovate UK.
Will SynaptixBio IPO soon?
No public IPO plans have been announced for SynaptixBio.
How can I track SynaptixBio secondary market activity?
Caplight tracks bids, offers, and trades in SynaptixBio's shares on secondary markets.